[go: up one dir, main page]

NO992114D0 - Pellets som har en kjerne belagt med et antisoppmiddel og en polymer - Google Patents

Pellets som har en kjerne belagt med et antisoppmiddel og en polymer

Info

Publication number
NO992114D0
NO992114D0 NO992114A NO992114A NO992114D0 NO 992114 D0 NO992114 D0 NO 992114D0 NO 992114 A NO992114 A NO 992114A NO 992114 A NO992114 A NO 992114A NO 992114 D0 NO992114 D0 NO 992114D0
Authority
NO
Norway
Prior art keywords
pellets
polymer
antifungal agent
core coated
coated
Prior art date
Application number
NO992114A
Other languages
English (en)
Other versions
NO325102B1 (no
NO992114L (no
Inventor
Roger Petrus Gerebe Vandecruys
Valentin Florent Victor Condu
Paul Marie Victor Gilis
Jozef Peeters
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO992114D0 publication Critical patent/NO992114D0/no
Publication of NO992114L publication Critical patent/NO992114L/no
Publication of NO325102B1 publication Critical patent/NO325102B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO19992114A 1997-03-26 1999-04-30 Pellets som har en kjerne belagt med itrakonazol og en polymer, farmasoytisk doseringsform inneholdende det samme, samt fremgangsmate ved fremstilling av pelletene. NO325102B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97200914 1997-03-26
PCT/EP1998/001773 WO1998042318A1 (en) 1997-03-26 1998-03-18 Pellets having a core coated with an antifungal and a polymer

Publications (3)

Publication Number Publication Date
NO992114D0 true NO992114D0 (no) 1999-04-30
NO992114L NO992114L (no) 1999-08-26
NO325102B1 NO325102B1 (no) 2008-02-04

Family

ID=8228147

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19992114A NO325102B1 (no) 1997-03-26 1999-04-30 Pellets som har en kjerne belagt med itrakonazol og en polymer, farmasoytisk doseringsform inneholdende det samme, samt fremgangsmate ved fremstilling av pelletene.

Country Status (30)

Country Link
EP (1) EP0969821B1 (no)
JP (1) JP3608800B2 (no)
KR (1) KR100520936B1 (no)
CN (1) CN1206984C (no)
AP (1) AP1227A (no)
AT (1) ATE241969T1 (no)
AU (1) AU734248B2 (no)
BG (1) BG64434B1 (no)
BR (1) BR9806174A (no)
CA (1) CA2269501C (no)
CY (1) CY2384B1 (no)
CZ (1) CZ295502B6 (no)
DE (1) DE69815316T2 (no)
DK (1) DK0969821T3 (no)
EE (1) EE03904B1 (no)
ES (1) ES2201485T3 (no)
HU (1) HU224217B1 (no)
ID (1) ID21477A (no)
IL (1) IL129575A (no)
NO (1) NO325102B1 (no)
NZ (1) NZ335364A (no)
OA (1) OA11162A (no)
PL (1) PL190566B1 (no)
PT (1) PT969821E (no)
RU (1) RU2218153C2 (no)
SI (1) SI0969821T1 (no)
SK (1) SK284813B6 (no)
TR (1) TR199900990T2 (no)
UA (1) UA60318C2 (no)
WO (1) WO1998042318A1 (no)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6663901B1 (en) * 1998-07-17 2003-12-16 Janssen Pharmaceutical N.V. Pellets having a core coated with an antifungal and a polymer
ES2157731B1 (es) 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
IL145140A0 (en) 1999-03-24 2002-06-30 Fmc Corp Improved aqueous solubility pharmaceutical formulations
KR100432949B1 (ko) * 2000-06-13 2004-05-31 코오롱제약주식회사 생체이용율이 향상된 이트라코나졸의 분립체 조성물과이를 이용한 이트라코나졸 제제 및 그 제조방법
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
NZ527391A (en) 2001-02-14 2005-04-29 Tibotec Pharm Ltd Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors
IL158092A0 (en) 2001-04-09 2004-03-28 Tibotec Pharm Ltd Broadspectrum 2- (substituted-amino)-benzoxazole sulfonamide hiv protease inhibitors
CZ304524B6 (cs) 2001-05-11 2014-06-18 Tibotec Pharmaceuticals Ltd. Derivát 2-aminobenzoxazolsulfonamidu, farmaceutická kompozice s jeho obsahem a léčivo pro léčení infekce retroviry
AU2002317063A (en) * 2001-06-12 2002-12-23 Smartrix Technologies Inc Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
US8071133B2 (en) 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
TWI336621B (en) 2001-12-21 2011-02-01 Tibotec Pharm Ltd Broad spectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
EP1517899B1 (en) 2002-05-17 2007-08-29 Tibotec Pharmaceuticals Ltd. Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors
AU2003262574B2 (en) 2002-08-14 2009-07-09 Tibotec Pharmaceuticals Ltd. Broadspectrum substituted oxindole sulfonamide HIV protease inhibitors
KR100557680B1 (ko) * 2002-11-23 2006-03-07 한국유나이티드제약 주식회사 이트라코나졸의 용해도 개선을 위한 펠렛제제 및 그제조방법
EP1438960B2 (en) * 2003-01-14 2012-12-19 Acino Pharma AG Compostion of itraconazole dispersed in a hydrophilic polymer having enhanced bioavailability
ES2283725T5 (es) * 2003-01-14 2014-11-28 Acino Pharma Ag Composición bioequivalente de itraconazol dispersada en un polímero hidrófilo
AU2004263130A1 (en) 2003-08-06 2005-02-17 Nirmal Mulye Pharmaceutical composition containing water soluble drug
CN1849117B (zh) 2003-09-11 2010-05-26 泰博特克药品有限公司 Hiv病毒的侵入抑制剂
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
AR048650A1 (es) 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
CA2566340C (en) 2004-05-07 2014-05-06 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
BRPI0511173A (pt) 2004-05-17 2007-12-04 Tibotec Pharm Ltd 1-fenil-1,5-diidro-pirido-(3,2b)indol-2-onas substituìdas nas posições 6,7,8,9, de utilidade como agentes farmacêuticos antiinfecciosos
US7622582B2 (en) 2004-05-17 2009-11-24 Tibotec Bvba Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one
AU2005243439B2 (en) 2004-05-17 2011-09-29 Tibotec Pharmaceuticals Ltd. 1-heterocyclyl-1,5-dihydro-pyrido(3,2-b)indol-2-ones
AU2007233683A1 (en) 2006-04-03 2007-10-11 Janssen R&D Ireland HIV inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones
BRPI0716481A2 (pt) * 2006-09-04 2014-03-18 Panacea Biotec Ltd Tecnologia de liberação flutuante programável
KR100809903B1 (ko) * 2006-09-05 2008-03-06 주식회사유한양행 안정화된 클로피도그렐-함유 입자, 그의 제조방법, 및 이를포함하는 약학 조성물
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
JP2008280254A (ja) * 2007-05-08 2008-11-20 Everest Pharm Industrial Co Ltd 生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物
US8313527B2 (en) 2007-11-05 2012-11-20 Allergan, Inc. Soft prosthesis shell texturing method
CN101965186A (zh) 2007-11-28 2011-02-02 塞阔伊亚药品公司 抑制细胞色素p450 2d6的化合物和方法
US8906647B2 (en) 2008-02-21 2014-12-09 Sequoia Pharmaceuticals, Inc. Diamide inhibitors of cytochrome P450
US9050184B2 (en) 2008-08-13 2015-06-09 Allergan, Inc. Dual plane breast implant
US8877822B2 (en) 2010-09-28 2014-11-04 Allergan, Inc. Porogen compositions, methods of making and uses
US9138309B2 (en) 2010-02-05 2015-09-22 Allergan, Inc. Porous materials, methods of making and uses
US9205577B2 (en) 2010-02-05 2015-12-08 Allergan, Inc. Porogen compositions, methods of making and uses
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
US11202853B2 (en) 2010-05-11 2021-12-21 Allergan, Inc. Porogen compositions, methods of making and uses
CN102971018B (zh) * 2010-05-11 2016-02-03 阿勒根公司 致孔剂组合物、制备方法及用途
US8679279B2 (en) 2010-11-16 2014-03-25 Allergan, Inc. Methods for creating foam-like texture
CN102100678B (zh) * 2011-02-18 2012-10-17 天津力生制药股份有限公司 伊曲康唑硫酸盐微丸及其制备方法
CA2895083A1 (en) 2012-12-13 2014-06-19 Allergan, Inc. Device and method for making a variable surface breast implant
US10092392B2 (en) 2014-05-16 2018-10-09 Allergan, Inc. Textured breast implant and methods of making same
JP6841834B2 (ja) * 2016-01-20 2021-03-10 テラヴィダ, インコーポレイテッドTheraVida, Inc. 多汗症の処置のための方法および組成物
HRP20240529T1 (hr) * 2018-04-16 2024-07-05 Bristol-Myers Squibb Company Formulacije apiksabana
CN114767636B (zh) * 2022-04-11 2023-11-07 苏州中化药品工业有限公司 伊曲康唑微丸、制备方法及伊曲康唑微丸胶囊

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
USH672H (en) * 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
ES2051968T3 (es) * 1988-12-22 1994-07-01 American Cyanamid Co Metodo para el tratamiento de enfermedad periodontal mediante la liberacion continua de un agente terapeutico a la bolsa periodontal; composicion de materia del mismo y aparato para su administracion.
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
CA2258683C (en) * 1996-06-28 2007-07-31 Schering Corporation Oral composition comprising a triazole antifungal compound

Also Published As

Publication number Publication date
PL190566B1 (pl) 2005-12-30
IL129575A (en) 2004-06-20
ES2201485T3 (es) 2004-03-16
BG103356A (en) 2000-03-31
IL129575A0 (en) 2000-02-29
TR199900990T2 (xx) 1999-10-21
DE69815316D1 (de) 2003-07-10
HU224217B1 (hu) 2005-06-28
SK54499A3 (en) 2000-01-18
OA11162A (en) 2003-04-16
SI0969821T1 (en) 2003-10-31
CA2269501A1 (en) 1998-10-01
EP0969821A1 (en) 2000-01-12
JP3608800B2 (ja) 2005-01-12
NO325102B1 (no) 2008-02-04
HUP0002056A2 (hu) 2000-12-28
NO992114L (no) 1999-08-26
WO1998042318A1 (en) 1998-10-01
JP2001520663A (ja) 2001-10-30
EP0969821B1 (en) 2003-06-04
EE9900453A (et) 2000-04-17
ATE241969T1 (de) 2003-06-15
CZ295502B6 (cs) 2005-08-17
CY2384B1 (en) 2004-06-04
KR100520936B1 (ko) 2005-10-17
AP9901516A0 (en) 1999-06-30
CZ139899A3 (cs) 1999-10-13
CA2269501C (en) 2005-11-08
PT969821E (pt) 2003-10-31
BR9806174A (pt) 1999-10-19
DK0969821T3 (da) 2003-09-15
BG64434B1 (en) 2005-02-28
SK284813B6 (sk) 2005-12-01
HK1022840A1 (en) 2000-08-25
UA60318C2 (uk) 2003-10-15
RU2218153C2 (ru) 2003-12-10
AU734248B2 (en) 2001-06-07
NZ335364A (en) 2000-08-25
CN1244796A (zh) 2000-02-16
AU7210798A (en) 1998-10-20
CN1206984C (zh) 2005-06-22
HUP0002056A3 (en) 2001-01-29
ID21477A (id) 1999-06-17
AP1227A (en) 2003-11-24
KR20000052971A (ko) 2000-08-25
PL335542A1 (en) 2000-04-25
EE03904B1 (et) 2002-12-16
DE69815316T2 (de) 2004-04-29

Similar Documents

Publication Publication Date Title
NO992114D0 (no) Pellets som har en kjerne belagt med et antisoppmiddel og en polymer
DK1104291T3 (da) Pelleter med en kerne, som er coatet med et antisvampemiddel og en polymer
FI950975L (fi) Antifungaalisella aineella ja polymeerilla päällystetyn ytimen käsittäviä helmiä
ID26275A (id) Jangkar dengan tiang pancang ulir
EP0746711A4 (en) LINEAR DIAPHRAGM VALVE
DE69721160D1 (de) Passiv adressierbare Ventile
DE69814476D1 (de) Bandkassette mit Kontaktteilen helfend bei dessen Ein- und Ausbau
NO20005426D0 (no) Pelleter med en kjerne som er belagt med et lipidsenkende middel og en polymer
DE69825506D1 (de) Plattengerät mit verbessertem Dämpfungsmittel
IT1303229B1 (it) Dispositivo per lavorazione a truciolo e relativo sopporto perutensile.
IT1281196B1 (it) Composizione erbicida selettiva a base di combinazioni di glifosfato e acifluorfene
ITMO970122A0 (it) Attrezzo particolarmente per allenamento ginnico sportivo e relativo u so.
DE69833520D1 (de) Bandführungsvorrichtung
IT236528Y1 (it) Struttura di sfera perfezionata per valvole con otturatore a sfera
KR950025658U (ko) 전화기가 부설된 컴퓨터
IT1268796B1 (it) Valvola a sfera perfezionata
IT237528Y1 (it) Valvola a sfera
IT1297578B1 (it) Valvola a sfera
ITMC950034V0 (it) Elettromagnete associato ad un alberino oscillante
ITTO950151V0 (it) Valvola a sfera perfezionata
SE9900736D0 (sv) Sårdyna samt förband innefattande en sådan sårdyna
LV11647A (lv) Panemiens datora aizsardzibai pret nesankcionetu pieeju
KR970019573U (ko) 저압 보빈의 저항 고정구조
IT238359Y1 (it) Struttura di valvola a sfera
IT1279956B1 (it) Dispositivo antiflessione per mensole, strutture a ponte e simili

Legal Events

Date Code Title Description
MK1K Patent expired